Reovirus type 3 binds to antagonist domains of the beta-adrenergic receptor.

AUTOR(ES)

Donta, S T

RESUMO

Reovirus type 3 interfered with the binding of beta-adrenergic antagonist ligands to receptors on Y1 adrenal, C6 glioma, and mouse L cells. This inhibition of beta-adrenergic binding was dose related. Reovirus did not interfere with dopaminergic binding or isoproterenol-induced activation of adenylate cyclase. In addition, reovirus infected Y1 cells, which bind beta-adrenergic antagonist ligands but lack agonist-induced activity. These results suggest that reovirus infection is initiated by binding to antagonist (nonfunctional) domains of the adrenergic receptor complex.

Documentos Relacionados

• Catecholamine binding to the beta-adrenergic receptor.
• Hormone-receptor interactions are noncooperative: application to the beta-adrenergic receptor.
• Structural similarities between the mammalian beta-adrenergic and reovirus type 3 receptors.
• Structural features required for ligand binding to the beta-adrenergic receptor.
• An antiidiotypic antibody that recognizes the beta-adrenergic receptor.